Biological_NP and_CC Clinical_NP Significance_NP of_IN Lipids_NP as_IN Modulators_NP of_IN Immune_NP System_NP Functions_NP null_NN Overall_RB ,_, the_DT integrated_JJ action_NN of_IN several_JJ polyunsaturated_JJ or_CC monounsaturated_JJ fatty_JJ acids_NNS on_IN the_DT immune_JJ system_NN includes_VBZ the_DT alteration_NN of_IN different_JJ immune_JJ functions_NNS in_IN both_DT humans_NNS and_CC animals_NNS ._SENT Therefore_RB ,_, lymphocyte_NN proliferation_NN ,_, production_NN of_IN cytokines_NNS ,_, modification_NN of_IN cell_NN surface_NN molecules_NNS ,_, changes_NNS in_IN phagocytic_JJ activity_NN ,_, and_CC alteration_NN of_IN natural_JJ killer_NN (_( NK_JJ )_) cell_NN activity_NN are_VBP susceptible_JJ to_TO be_VB modulated_VBN by_IN dietary_JJ lipid_NN administration_NN or_CC by_IN culture_NN of_IN cells_NNS in_IN the_DT presence_NN of_IN several_JJ free_JJ fatty_JJ acids_NNS ._SENT However_RB ,_, it_PP is_VBZ important_JJ to_TO note_VB that_IN not_RB all_RB of_IN the_DT fatty_JJ acids_NNS have_VBP the_DT same_JJ immunomodulatory_JJ properties_NNS ._SENT Thus_RB ,_, long-chain_JJ n-3_JJ polyunsaturated_JJ fatty_JJ acids_NNS ,_, such_JJ as_IN EPA_NP (_( 20:5n-3_JJ )_) or_CC DHA_NP (_( 22:6n-3_JJ )_) (_( which_WDT belong_VBP to_TO n-3_JJ fatty_JJ acid_NN series_NN derived_VBN from_IN fish_NN oil_NN )_) are_VBP particularly_RB known_VBN to_TO exert_VB a_DT profound_JJ influence_NN on_IN the_DT immune_JJ system_NN ,_, reducing_VBG many_JJ of_IN these_DT functions_NNS previously_RB described_VBD for_IN both_DT humans_NNS and_CC animals_NNS ._SENT Other_JJ fatty_JJ acids_NNS belonging_VBG to_TO n-6_JJ fatty_JJ acid_NN series_NN such_JJ as_IN AA_NP (_( 20:4n-6_JJ )_) have_VBP also_RB been_VBN reported_VBN to_TO affect_VB the_DT immune_JJ system_NN ;_: although_IN AA_NP has_VBZ not_RB been_VBN shown_VBN to_TO produce_VB an_DT immunosuppression_NN as_IN relevant_JJ as_IN long-chain_JJ n-3_JJ fatty_JJ acids_NNS ,_, it_PP is_VBZ also_RB considered_VBN an_DT immunosuppressive_JJ agent_NN ._SENT Nevertheless_RB ,_, both_DT n-6_JJ polyunsaturated_JJ fatty_JJ acids_NNS and_CC saturated_JJ fatty_JJ acids_NNS have_VBP been_VBN associated_VBN to_TO a_DT chemopromotive_JJ role_NN in_IN cancer_NN ,_, probably_RB due_JJ in_IN part_NN to_TO a_DT suppression_NN of_IN apoptosis_NN ._SENT However_RB ,_, oleic_JJ acid_NN (_( a_DT monounsaturated_JJ fatty_JJ acid_NN [_SYM 18:1n-9_NP ]_SYM that_WDT is_VBZ the_DT main_JJ component_NN of_IN olive_JJ oil_NN belonging_VBG to_TO n-9_JJ fatty_JJ acid_NN series_NN )_) is_VBZ also_RB capable_JJ of_IN acting_VBG as_IN a_DT modulator_NN of_IN immune_JJ functions_NNS ._SENT Accordingly_RB ,_, olive_JJ oil_NN (_( a_DT traditional_JJ and_CC essential_JJ component_NN of_IN the_DT Mediterranean_NP diet_NN )_) also_RB plays_VBZ an_DT important_JJ role_NN in_IN the_DT modulation_NN of_IN immune_JJ functions_NNS ,_, and_CC therefore_RB it_PP has_VBZ been_VBN efficiently_RB applied_VBN in_IN the_DT alleviation_NN of_IN the_DT symptomatology_NN caused_VBN by_IN rheumatoid_JJ arthritis_NN ._SENT Differential_JJ properties_NNS of_IN fatty_JJ acids_NNS and_CC their_PP$ role_NN in_IN the_DT modulation_NN of_IN immune_JJ system_NN functions_NNS ._SENT |_SYM The_DT changes_NNS attributed_VBD to_TO fatty_JJ acid_NN administration_NN include_VBP the_DT reduction_NN of_IN lymphocyte_NN proliferation_NN ,_, which_WDT is_VBZ modified_VBN by_IN polyunsaturated_JJ fatty_JJ acids_NNS (_( n-3_JJ or_CC n-6_JJ )_) or_CC monounsaturated_JJ fatty_JJ acids_NNS (_( n-9_JJ )_) ._SENT Studies_NNS carried_VBD out_RP in_IN both_DT humans_NNS and_CC animals_NNS have_VBP revealed_VBN that_IN the_DT administration_NN of_IN high_JJ levels_NNS of_IN dietary_JJ n-3_JJ polyunsaturated_JJ fatty_JJ acids_NNS or_CC the_DT inclusion_NN in_IN parenteral_JJ regimens_NNS of_IN lipid_NN emulsions_NNS rich_JJ in_IN n-3_JJ or_CC n-9_JJ fatty_JJ acids_NNS are_VBP related_VBN to_TO the_DT reduction_NN of_IN lymphocyte_NN proliferation_NN during_IN the_DT supplementation_NN ._SENT Thus_RB ,_, concanavalin-A_NN or_CC lipopolysaccharide-stimulated_JJ lymphocytes_NNS have_VBP reduced_VBN the_DT cellular_JJ proliferation_NN in_IN assays_NNS carried_VBN out_RP in_IN vitro_NN or_CC ex_JJ vivo_RB in_IN the_DT presence_NN of_IN free_JJ fatty_JJ acids_NNS or_CC in_IN cell_NN cultures_NNS from_IN both_DT animals_NNS and_CC humans_NNS fed_VBD dietary_JJ lipids_NNS ,_, respectively_RB ._SENT Cytokine_NN production_NN is_VBZ reduced_VBN by_IN the_DT action_NN of_IN n-3_JJ polyunsaturated_JJ fatty_JJ acids_NNS or_CC n-9_JJ monounsaturated_JJ fatty_JJ acids_NNS ,_, cytokine_JJ receptor_NN expression_NN is_VBZ also_RB affected_JJ ,_, natural_JJ killer_NN (_( NK_JJ )_) activity_NN is_VBZ significantly_RB suppressed_VBN ,_, phagocytic_JJ activity_NN of_IN macrophages_NNS is_VBZ modified_VBN ,_, and_CC the_DT antigen-presenting_JJ function_NN of_IN human_JJ monocytes_NNS is_VBZ inhibited_VBN ._SENT Based_VBN on_IN these_DT experimental_JJ observations_NNS ,_, we_PP can_MD affirm_VB that_DT n-3_JJ polyunsaturated_JJ fatty_JJ acids_NNS rather_RB than_IN n-6_JJ polyunsaturated_JJ or_CC n-9_JJ monounsaturated_JJ fatty_JJ acids_NNS are_VBP directly_RB associated_VBN to_TO the_DT alteration_NN of_IN immune_JJ and_CC inflammatory_JJ response_NN ._SENT This_DT modulation_NN depends_VBZ on_IN different_JJ factors_NNS ,_, such_JJ as_IN the_DT nature_NN of_IN fatty_JJ acids_NNS added_VBD to_TO diets_NNS ,_, the_DT concentration_NN of_IN fatty_JJ acids_NNS ,_, the_DT duration_NN of_IN supplementation_NN with_IN dietary_JJ lipids_NNS ,_, or_CC differences_NNS among_IN animal_JJ species_NNS fed_VBD dietary_JJ lipids_NNS ._SENT Mechanisms_NNS of_IN action_NN ._SENT |_SYM As_RB mentioned_VBN previously_RB ,_, for_IN several_JJ years_NNS numerous_JJ studies_NNS have_VBP attempted_VBN to_TO elucidate_VB the_DT mechanisms_NNS by_IN which_WDT some_DT dietary_JJ lipids_NNS produce_VBP a_DT potential_JJ effect_NN on_IN immune_JJ system_NN functions_NNS ._SENT Several_JJ hypotheses_NNS have_VBP been_VBN suggested_VBN as_IN possible_JJ mechanisms_NNS ._SENT Experimental_JJ investigations_NNS have_VBP confirmed_VBN that_IN several_JJ fatty_JJ acids_NNS exert_VBP changes_NNS in_IN the_DT phospholipids_NNS of_IN plasma_NN membrane_NN which_WDT affect_VBP the_DT membrane_NN fluidity_NN ;_: they_PP also_RB alter_VBP eicosanoid_JJ production_NN ,_, produce_VB lipid_NN peroxides_NNS ,_, or_CC regulate_VB the_DT transcription_NN factors_NNS ._SENT Overall_RB ,_, long-chain_JJ n-3_JJ polyunsaturated_JJ fatty_JJ acids_NNS ,_, such_JJ as_IN EPA_NP ,_, are_VBP incorporated_VBN into_IN cell_NN membranes_NNS ,_, replacing_VBG AA_NP (_( the_DT most_RBS important_JJ of_IN the_DT eicosanoid_JJ precursors_NNS )_) ._SENT This_DT process_NN reduces_VBZ the_DT production_NN of_IN a_DT biological_JJ mediator_NN as_IN prostaglandin_NN E2_NN responsible_JJ for_IN inhibiting_VBG IL-1_JJ and_CC tumor_NN necrosis_NN factor_NN (_( TNF_NP )_) production_NN ._SENT Similarly_RB ,_, EPA_NP inhibits_VBZ gene_NN transcription_NN because_IN it_PP reduces_VBZ the_DT translocation_NN of_IN NF-kappaB_NP ._SENT In_IN addition_NN to_TO these_DT important_JJ considerations_NNS ,_, a_DT crucial_JJ role_NN of_IN lymphocyte_NN subsets_NNS has_VBZ been_VBN suggested_VBN to_TO explain_VB the_DT effects_NNS of_IN different_JJ dietary_JJ polyunsaturated_JJ fatty_JJ acids_NNS on_IN the_DT immune_JJ system_NN ,_, because_IN they_PP alter_VBP the_DT number_NN of_IN lymphocyte_NN subsets_NNS as_RB well_RB as_IN the_DT proliferation_NN of_IN these_DT cells_NNS ._SENT Thus_RB ,_, antigen_NN presentation_NN and_CC the_DT proportion_NN of_IN T-cell_NN subsets_NNS are_VBP modified_VBN after_IN dietary_JJ lipid_NN manipulation_NN ._SENT In_IN fact_NN ,_, recent_JJ studies_NNS have_VBP determined_VBN that_IN polyunsaturated_JJ fatty_JJ acids_NNS inhibit_VBP the_DT surface_NN expression_NN of_IN major_JJ histocompatibility_NN complex_NN (_( MHC_NP )_) class_NN II_CD molecules_NNS ,_, as_RB well_RB as_IN some_DT adhesion_NN molecules_NNS on_IN human_JJ monocytes_NNS ._SENT Similarly_RB ,_, consumption_NN of_IN a_DT monounsaturated_JJ fatty_JJ acid-rich_JJ diet_NN by_IN humans_NNS is_VBZ also_RB involved_VBN in_IN the_DT reduction_NN of_IN adhesion_NN molecules_NNS from_IN peripheral_JJ blood_NN mononuclear_JJ cells_NNS ._SENT Overall_RB ,_, these_DT actions_NNS may_MD explain_VB the_DT different_JJ expression_NN of_IN CD4_NP or_CC CD8_NP on_IN the_DT T-cell_NN surfaces_VBZ of_IN peripheral_JJ blood_NN mononuclear_JJ cells_NNS of_IN mice_NNS that_WDT were_VBD fed_VBN diets_NNS supplemented_VBN with_IN DHA_NP ._SENT The_DT biological_JJ consequences_NNS of_IN these_DT changes_NNS are_VBP still_RB unclear_JJ ._SENT It_PP is_VBZ probable_JJ that_IN the_DT alteration_NN experimented_VBN by_IN the_DT lymphocyte_NN population_NN enhances_VBZ the_DT host_NN susceptibility_NN against_IN opportunistic_JJ infections_NNS ._SENT In_IN other_JJ words_NNS ,_, the_DT modulation_NN of_IN lymphocyte_NN subsets_NNS may_MD lead_VB in_IN part_NN to_TO a_DT modification_NN of_IN cytokine_NN production_NN ,_, NK_JJ cell_NN activity_NN ,_, antibody_NN production_NN ,_, etc._FW Accordingly_RB ,_, Th1-type_NP cytokines_NNS such_JJ as_IN IL-2_NN are_VBP more_RBR susceptible_JJ to_TO polyunsaturated_JJ fatty_JJ acid_NN effects_NNS than_IN are_VBP Th2-type_NP cytokines_NNS ,_, such_JJ as_IN IL-4_NN ,_, which_WDT indicates_VBZ that_IN these_DT fatty_JJ acids_NNS are_VBP capable_JJ of_IN altering_VBG the_DT balance_NN of_IN Th1-_NP and_CC Th2-type_NP cytokines_NNS in_IN mice_NNS ._SENT As_IN a_DT direct_JJ consequence_NN of_IN a_DT reduction_NN of_IN IL-2_JJ production_NN ,_, Th1_JJ cell_NN activation_NN is_VBZ suppressed_VBN ,_, whereas_IN an_DT increase_NN of_IN Th2_NP cell_NN activation_NN due_JJ to_TO an_DT enhancement_NN of_IN IL-4_NN production_NN suppresses_VBZ Th1_JJ cell_NN proliferation_NN in_IN animals_NNS fed_VBD a_DT diet_NN containing_VBG fish_NN oil_NN ._SENT Therefore_RB ,_, the_DT anti-inflammatory_JJ effects_NNS derived_VBN from_IN long-chain_JJ n-3_JJ polyunsaturated_JJ fatty_JJ acid_NN administration_NN may_MD be_VB the_DT result_NN of_IN these_DT two_CD interconnected_VBN mechanisms_NNS ._SENT Hence_RB ,_, it_PP is_VBZ obvious_JJ that_IN these_DT alterations_NNS may_MD affect_VB significantly_RB the_DT interaction_NN between_IN host_NN natural_JJ resistance_NN and_CC infectious_JJ agents_NNS due_JJ to_TO the_DT crucial_JJ importance_NN of_IN Th1-mediated_JJ response_NN in_IN the_DT infectious_JJ processes_NNS promoted_VBN by_IN viruses_NNS or_CC bacteria_NNS ._SENT Although_IN results_NNS from_IN epidemiological_JJ ,_, experimental_JJ ,_, or_CC clinical_JJ studies_NNS have_VBP demonstrated_VBN an_DT important_JJ association_NN between_IN n-3_JJ polyunsaturated_JJ fatty_JJ acids_NNS and_CC immunosuppressive_JJ properties_NNS in_IN both_DT humans_NNS and_CC animals_NNS ,_, their_PP$ effects_NNS are_VBP complex_JJ and_CC still_RB not_RB clearly_RB known_VBN ._SENT In_IN fact_NN ,_, some_DT discrepant_JJ results_NNS have_VBP suggested_VBN that_IN n-3_JJ polyunsaturated_JJ fatty_JJ acids_NNS have_VBP stimulatory_JJ effects_NNS on_IN TNF_NP and_CC IL-1_NP production_NN ._SENT Evidence_NN for_IN the_DT involvement_NN of_IN fatty_JJ acids_NNS in_IN apoptosis_NN modulation_NN ._SENT |_SYM Programmed_NP cell_NN death_NN or_CC apoptosis_NN has_VBZ been_VBN defined_VBN as_IN an_DT essential_JJ mechanism_NN responsible_JJ for_IN the_DT regulation_NN of_IN homeostasis_NN ,_, tissue_NN development_NN ,_, or_CC immune_JJ functions_NNS ._SENT Thus_RB ,_, damaged_JJ ,_, aberrant_JJ ,_, or_CC unnecessary_JJ cells_NNS must_MD be_VB eliminated_VBN to_TO ensure_VB the_DT correct_JJ development_NN of_IN multicellular_JJ organisms_NNS ._SENT Irrespective_RB of_IN its_PP$ crucial_JJ role_NN in_IN normal_JJ cell_NN control_NN ,_, apoptosis_NN regulates_VBZ pathological_JJ processes_NNS including_VBG human_JJ clinical_JJ disorders_NNS such_JJ as_IN cancer_NN ,_, autoimmune_JJ diseases_NNS ,_, viral_JJ or_CC bacterial_JJ infections_NNS ,_, and_CC neurodegenerative_JJ disorders_NNS ._SENT Several_JJ biological_JJ factors_NNS (_( many_JJ viruses_NNS ,_, bacteria_NNS ,_, or_CC parasites_NNS )_) ,_, chemical_NN factors_NNS (_( glucocorticoids_NNS ,_, ceramides_NNS ,_, etc._FW )_) ,_, and_CC physical_JJ factors_NNS (_( irradiation_NN )_) are_VBP responsible_JJ for_IN apoptosis_NN induction_NN ._SENT Moreover_RB ,_, different_JJ studies_NNS with_IN both_DT animals_NNS and_CC humans_NNS ,_, involving_VBG in_IN vitro_NN assays_NNS or_CC administration_NN of_IN dietary_JJ lipids_NNS ,_, have_VBP recently_RB described_VBN an_DT important_JJ role_NN of_IN several_JJ fatty_JJ acids_NNS in_IN the_DT induction_NN or_CC inhibition_NN of_IN apoptosis_NN ._SENT As_IN a_DT result_NN ,_, different_JJ mechanisms_NNS of_IN action_NN have_VBP been_VBN proposed_VBN in_IN order_NN to_TO explain_VB the_DT action_NN of_IN fatty_JJ acids_NNS on_IN apoptosis_NN modulation_NN ._SENT Thus_RB ,_, polyunsaturated_JJ fatty_JJ acids_NNS ,_, such_JJ as_IN EPA_NP and_CC DHA_NP ,_, saturated_VBD fatty_JJ acids_NNS ,_, such_JJ as_IN PA_NP ,_, or_CC fats_NNS such_JJ as_IN fish_NN oil_NN administered_VBN in_IN the_DT diets_NNS have_VBP been_VBN defined_VBN as_IN substances_NNS capable_JJ of_IN inducing_VBG cell_NN death_NN via_IN a_DT mitochondrial_JJ process_NN or_CC by_IN downregulation_NN of_IN Bcl-2_NP ._SENT Different_JJ mechanisms_NNS have_VBP been_VBN proposed_VBN in_IN order_NN to_TO explain_VB the_DT induction_NN of_IN apoptosis_NN by_IN certain_JJ fatty_JJ acids_NNS ._SENT Thus_RB ,_, PA_NP (_( a_DT saturated_JJ fatty_JJ acid_NN )_) added_VBD to_TO cellular_JJ cultures_NNS in_IN in_IN vitro_NN assays_NNS induces_VBZ apoptosis_NN via_IN a_DT direct_JJ effect_NN on_IN mitochondria_NNS ,_, because_IN it_PP causes_VBZ a_DT dissipation_NN of_IN the_DT mitochondrial_JJ transmembrane_NN potential_NN (_( DeltaPsim_NP )_) ,_, an_DT event_NN that_WDT precedes_VBZ nuclear_JJ apoptosis_NN ._SENT Another_DT possible_JJ partial_JJ explanation_NN for_IN the_DT modulation_NN of_IN apoptosis_NN by_IN long-chain_JJ n-3_JJ polyunsaturated_JJ fatty_JJ acids_NNS is_VBZ that_IN it_PP is_VBZ caused_VBN by_IN direct_JJ action_NN of_IN these_DT substances_NNS on_IN the_DT cells_NNS and_CC by_IN activation_NN of_IN the_DT caspase_NN cascade_NN through_IN cytochrome_NN c_NN release_NN coupled_VBN with_IN a_DT modulation_NN of_IN mitochondrial_JJ membrane_NN depolarization_NN ._SENT Recent_JJ studies_NNS have_VBP also_RB determined_VBN the_DT crucial_JJ importance_NN of_IN dietary_JJ fatty_JJ acids_NNS in_IN the_DT reduction_NN of_IN Bcl-2_NP expression_NN as_RB well_RB as_IN an_DT increase_NN of_IN Fas_NP ligand_NN (_( Fas-L_NP )_) expression_NN ._SENT Therefore_RB ,_, when_WRB the_DT concentration_NN of_IN polyunsaturated_JJ fatty_JJ acids_NNS augments_NNS ,_, Bcl-2_JJ expression_NN is_VBZ reduced_VBN and_CC cell_NN death_NN occurs_VBZ ._SENT In_IN other_JJ words_NNS ,_, long-chain_JJ fatty_JJ acids_NNS contained_VBN in_IN fish_NN oil_NN trigger_NN apoptosis_NN by_IN suppressing_VBG Bcl-2_JJ expression_NN and_CC increasing_VBG Fas-L_NP expression_NN ._SENT On_IN the_DT other_JJ hand_NN ,_, it_PP has_VBZ been_VBN recently_RB determined_VBN that_IN Ras_NP membrane_NN localization_NN (_( a_DT protein_NN that_WDT plays_VBZ a_DT critical_JJ role_NN in_IN the_DT cell_NN growth_NN and_CC apoptosis_NN )_) is_VBZ reduced_VBN after_IN administration_NN of_IN fish_NN oil_NN ,_, which_WDT indicates_VBZ that_DT dietary_JJ fish_NN oil_NN may_MD play_VB a_DT protective_JJ role_NN against_IN colon_NN cancer_NN development_NN ._SENT Finally_RB ,_, it_PP is_VBZ important_JJ to_TO note_VB that_DT lipid_NN peroxidation_NN is_VBZ of_IN crucial_JJ importance_NN in_IN apoptosis_NN induction_NN ._SENT This_DT argument_NN suggests_VBZ that_IN the_DT effects_NNS of_IN polyunsaturated_JJ fatty_JJ acids_NNS can_MD be_VB directly_RB associated_VBN to_TO specific_JJ alterations_NNS on_IN the_DT expression_NN of_IN Bcl-2_NP ,_, Fas_NP ,_, and_CC Ras_NP ._SENT Early_JJ studies_NNS revealed_VBD the_DT importance_NN of_IN n-3_JJ polyunsaturated_JJ fatty_JJ acids_NNS as_IN possible_JJ therapeutic_JJ substances_NNS capable_JJ of_IN reducing_VBG the_DT incidence_NN of_IN inflammatory_JJ disorders_NNS in_IN humans_NNS ._SENT Autoimmune_JJ diseases_NNS such_JJ as_IN rheumatoid_JJ arthritis_NN ,_, psoriasis_NN ,_, or_CC systemic_JJ lupus_NN erythematosus_NNS are_VBP characterized_VBN by_IN the_DT production_NN of_IN an_DT inflammatory_JJ response_NN due_JJ to_TO a_DT marked_JJ increase_NN of_IN proinflammatory_JJ cytokines_NNS ._SENT In_IN recent_JJ years_NNS ,_, numerous_JJ epidemiological_JJ studies_NNS have_VBP described_VBN widely_RB the_DT reduction_NN in_IN the_DT incidence_NN of_IN rheumatoid_JJ arthritis_NN in_IN populations_NNS who_WP consume_VBP fish_NN oil_NN or_CC olive_JJ oil_NN in_IN their_PP$ diets_NNS ,_, which_WDT are_VBP related_VBN to_TO the_DT prevention_NN of_IN inflammatory_JJ disorder_NN incidence_NN ,_, although_IN these_DT events_NNS occur_VBP after_IN a_DT prolonged_JJ ingestion_NN of_IN these_DT fats_NNS (_( ,_, -_: ,_, ,_, )_) ._SENT Nevertheless_RB ,_, in_IN spite_NN of_IN the_DT importance_NN of_IN these_DT substances_NNS as_IN biological_JJ mediators_NNS in_IN the_DT inflammation_NN and_CC their_PP$ application_NN in_IN the_DT resolution_NN of_IN inflammatory_JJ diseases_NNS ,_, in_IN the_DT present_JJ review_NN we_PP will_MD summarize_VB other_JJ important_JJ features_NNS of_IN fatty_JJ acids_NNS from_IN a_DT clinical_JJ point_NN of_IN view_NN ,_, focusing_VBG on_IN the_DT potential_JJ effect_NN of_IN fatty_JJ acids_NNS in_IN cancer_NN incidence_NN and_CC the_DT involvement_NN of_IN these_DT substances_NNS in_IN the_DT alteration_NN of_IN host_NN natural_JJ resistance_NN against_IN infectious_JJ agents_NNS ._SENT Crucial_JJ role_NN of_IN fatty_JJ acids_NNS in_IN the_DT incidence_NN of_IN cancer_NN ._SENT |_SYM Many_JJ lines_NNS of_IN evidence_NN have_VBP indicated_VBN the_DT essential_JJ role_NN of_IN fish_NN oil_NN in_IN the_DT incidence_NN of_IN cancer_NN ._SENT Numerous_JJ reports_NNS have_VBP suggested_VBN that_IN high_JJ intakes_NNS of_IN long-chain_JJ n-3_JJ fatty_JJ acids_NNS or_CC n-9_JJ fatty_JJ acids_NNS (_( the_DT most_RBS important_JJ fatty_JJ acid_NN contained_VBN in_IN olive_JJ oil_NN )_) may_MD reduce_VB the_DT risk_NN of_IN breast_NN cancer_NN in_IN both_DT humans_NNS and_CC animals_NNS ._SENT Thus_RB ,_, n-3_JJ polyunsaturated_JJ fatty_JJ acids_NNS may_MD inhibit_VB colon_NN cancer_NN in_IN rats_NNS as_IN well_RB as_RB reduce_VB the_DT risk_NN of_IN colorectal_JJ cancer_NN development_NN ._SENT In_IN contrast_NN ,_, n-6_JJ fatty_JJ acids_NNS or_CC saturated_JJ fatty_JJ acids_NNS may_MD be_VB involved_VBN in_IN the_DT increase_NN of_IN mammary_JJ or_CC colon_NN tumorigenesis_NN by_IN altering_VBG membrane_NN phospholipid_NN turnover_NN ._SENT Accordingly_RB ,_, AA_NP is_VBZ released_VBN from_IN plasma_NN membrane_NN that_WDT produces_VBZ an_DT alteration_NN in_IN the_DT synthesis_NN of_IN prostaglandins_NNS via_IN cyclooxygenase_NN enzyme_NN ._SENT Epidemiological_JJ studies_NNS have_VBP determined_VBN the_DT protective_JJ role_NN of_IN n-3_JJ polyunsaturated_JJ fatty_JJ acids_NNS against_IN colon_NN cancer_NN in_IN populations_NNS of_IN Alaskan_JJ and_CC Greenland_NP Eskimos_NNS ._SENT Subsequently_RB ,_, experimental_JJ studies_NNS demonstrated_VBD that_IN a_DT fish_NN oil_NN diet_NN appears_VBZ to_TO exert_VB a_DT protective_JJ effect_NN against_IN experimentally_RB induced_VBN colon_NN cancer_NN ._SENT Similarly_RB ,_, a_DT recent_JJ study_NN has_VBZ determined_VBN that_DT olive_JJ oil_NN also_RB exerts_VBZ a_DT protective_JJ role_NN against_IN the_DT development_NN of_IN colorectal_JJ cancer_NN ._SENT Although_IN the_DT mechanisms_NNS that_WDT contribute_VBP to_TO this_DT protective_JJ effect_NN have_VBP not_RB been_VBN elucidated_VBN ,_, a_DT recent_JJ investigation_NN has_VBZ reported_VBN that_DT fish_NN oil_NN diets_NNS are_VBP able_JJ to_TO increase_VB apoptosis_NN and_CC cell_NN differentiation_NN in_IN induced_VBN rat_NN colon_NN tumorigenesis_NN ._SENT Based_VBN on_IN current_JJ knowledge_NN ,_, an_DT interesting_JJ study_NN has_VBZ recently_RB determined_VBN that_IN the_DT Western_JJ diet_NN (_( which_WDT consists_VBZ predominantly_RB of_IN a_DT mixture_NN of_IN saturated_JJ ,_, monounsaturated_JJ ,_, and_CC polyunsaturated_JJ fats_NNS )_) produces_VBZ dysplastic_JJ lesions_NNS in_IN the_DT colon_NN ,_, which_WDT is_VBZ indicative_JJ of_IN a_DT tumorigenic_JJ process_NN ._SENT As_IN a_DT result_NN ,_, the_DT administration_NN of_IN a_DT diet_NN containing_VBG mixed_JJ lipids_NNS and_CC high_JJ levels_NNS of_IN saturated_JJ fatty_JJ acids_NNS (_( similar_JJ to_TO the_DT lipids_NNS contained_VBN in_IN the_DT Western_JJ diet_NN )_) induces_VBZ colon_NN carcinogenesis_NN in_IN mice_NNS by_IN an_DT unknown_JJ mechanism_NN ._SENT Nevertheless_RB ,_, the_DT most_RBS interesting_JJ results_NNS from_IN this_DT investigation_NN reveal_VBP that_IN an_DT alteration_NN of_IN cyclooxygenase_NN activity_NN as_RB well_RB as_IN apoptosis_NN suppression_NN appears_VBZ to_TO play_VB a_DT crucial_JJ role_NN in_IN the_DT colon_NN tumorigenesis_NN induced_VBN by_IN this_DT diet_NN in_IN animal_JJ models_NNS ._SENT In_IN addition_NN ,_, our_PP$ experimental_JJ observations_NNS have_VBP indicated_VBN that_IN the_DT survival_NN of_IN mice_NNS fed_VBD a_DT diet_NN containing_VBG fish_NN oil_NN and_CC transplanted_VBN with_IN a_DT T-lymphoma_NP cell_NN line_NN is_VBZ reduced_VBN in_IN comparison_NN to_TO that_WDT of_IN mice_NNS fed_VBD a_DT diet_NN containing_VBG low_JJ fat_NN ._SENT We_PP speculate_VBP that_IN this_DT event_NN may_MD be_VB attributed_VBN to_TO the_DT impairment_NN in_IN the_DT function_NN of_IN T_NN cells_NNS or_CC NK_JJ cells_NNS due_JJ to_TO polyunsaturated_JJ fatty_JJ acid_NN administration_NN ,_, which_WDT reduces_VBZ the_DT cytotoxic_JJ activity_NN of_IN NK_JJ cells_NNS ._SENT Recently_RB ,_, an_DT interesting_JJ investigation_NN has_VBZ shown_VBN that_IN n-3_JJ fatty_JJ acids_NNS alter_VBP cell_NN transformation_NN in_IN a_DT mouse_NN epidermal_JJ cell_NN line_NN because_IN DHA_NP or_CC EPA_NP inhibited_VBD transcription_NN activator_NN protein_NN AP-1_NP whereas_IN AA_NP did_VBD not_RB produce_VB any_DT effect_NN on_IN AP-1_JJ activity_NN ._SENT Therefore_RB ,_, this_DT finding_NN confirms_VBZ previous_JJ reports_NNS of_IN the_DT chemoprotective_JJ role_NN of_IN diets_NNS containing_VBG n-3_JJ fatty_JJ acids_NNS ._SENT In_IN contrast_NN ,_, the_DT most_RBS significant_JJ relationship_NN between_IN fatty_JJ acids_NNS and_CC reduction_NN of_IN cancer_NN incidence_NN is_VBZ found_VBN in_IN the_DT Mediterranean_JJ diet_NN ,_, which_WDT could_MD decrease_VB the_DT development_NN of_IN cancer_NN by_IN up_IN to_TO 10_CD to_TO 15_CD %_NN in_IN the_DT populations_NNS of_IN highly_RB developed_VBN Western_JJ countries_NNS ._SENT In_IN spite_NN of_IN the_DT wide_JJ information_NN currently_RB available_JJ ,_, the_DT potential_JJ role_NN of_IN dietary_JJ lipids_NNS in_IN cancer_NN etiology_NN remains_VBZ controversial_JJ ._SENT In_IN fact_NN ,_, although_IN most_JJS of_IN the_DT studies_NNS have_VBP shown_VBN that_IN diets_NNS containing_VBG n-3_JJ polyunsaturated_JJ fatty_JJ acids_NNS might_MD be_VB beneficial_JJ during_IN inflammatory_JJ conditions_NNS ,_, their_PP$ effects_NNS are_VBP not_RB elucidated_VBN because_IN they_PP promote_VBP an_DT impairment_NN of_IN the_DT host_NN defense_NN to_TO infection_NN ._SENT Therefore_RB ,_, future_JJ studies_NNS are_VBP needed_VBN in_IN order_NN to_TO confirm_VB or_CC refute_VB the_DT different_JJ hypotheses_NNS and_CC arguments_NNS suggested_VBD hitherto_RB ._SENT Relevance_NN of_IN dietary_JJ lipids_NNS in_IN the_DT reduction_NN of_IN host_NN natural_JJ resistance_NN and_CC susceptibility_NN to_TO infection_NN ._SENT |_SYM As_RB mentioned_VBN above_JJ ,_, nutrient_JJ intake_NN is_VBZ considered_VBN a_DT critical_JJ determinant_NN of_IN immunocompetence_NN ._SENT Many_JJ investigations_NNS have_VBP reported_VBN the_DT modulatory_JJ functions_NNS exerted_VBN by_IN fatty_JJ acids_NNS and_CC the_DT clinical_JJ benefits_NNS of_IN dietary_JJ lipid_NN supplementation_NN with_IN fish_NN oil_NN or_CC olive_JJ oil_NN in_IN both_DT humans_NNS and_CC animals_NNS ._SENT As_IN a_DT consequence_NN ,_, this_DT dietary_JJ supplementation_NN has_VBZ been_VBN applied_VBN in_IN the_DT treatment_NN of_IN patients_NNS suffering_VBG from_IN inflammatory_JJ diseases_NNS ,_, because_IN unsaturated_JJ fatty_JJ acids_NNS (_( mainly_RB n-3_JJ or_CC n-9_JJ fatty_JJ acids_NNS )_) reduce_VBP the_DT levels_NNS of_IN many_JJ biological_JJ mediators_NNS associated_VBN to_TO the_DT promotion_NN of_IN the_DT inflammatory_JJ events_NNS that_WDT participate_VBP in_IN an_DT inappropriate_JJ immune_JJ response_NN ._SENT However_RB ,_, the_DT reported_VBN reduction_NN of_IN immune_JJ response_NN caused_VBN by_IN the_DT administration_NN in_IN the_DT diet_NN of_IN some_DT fatty_JJ acids_NNS may_MD exert_VB a_DT detrimental_JJ effect_NN ,_, and_CC therefore_RB ,_, they_PP may_MD impair_VB the_DT cellular_JJ immunity_NN to_TO pathogenic_JJ agents_NNS ._SENT For_IN obvious_JJ reasons_NNS ,_, the_DT altered_JJ resistance_NN to_TO bacterial_JJ infection_NN has_VBZ been_VBN analyzed_VBN in_IN animal_JJ models_NNS in_IN which_WDT the_DT administration_NN of_IN diets_NNS containing_VBG fish_NN oil_NN reduces_VBZ the_DT clearance_NN of_IN bacteria_NNS from_IN liver_NN or_CC spleen_NN and_CC significantly_RB reduces_VBZ the_DT survival_NN during_IN the_DT course_NN of_IN Listeria_NN monocytogenes_NNS infection_NN ._SENT As_IN a_DT result_NN ,_, the_DT elimination_NN of_IN pathogenic_JJ agents_NNS (_( bacteria_NNS ,_, viruses_NNS ,_, or_CC parasites_NNS )_) is_VBZ more_RBR difficult_JJ ._SENT Different_JJ reports_NNS have_VBP described_VBN the_DT clinical_JJ consequences_NNS of_IN dietary_JJ supplementation_NN rich_JJ in_IN n-3_JJ fatty_JJ acids_NNS that_WDT suppress_VBP the_DT immune_JJ system_NN functions_NNS ._SENT Thus_RB ,_, a_DT significant_JJ reduction_NN of_IN survival_NN percentage_NN after_IN feeding_VBG experimental_JJ mice_NNS with_IN a_DT diet_NN containing_VBG fish_NN oil_NN has_VBZ been_VBN determined_VBN whereas_IN an_DT increase_NN of_IN survival_NN percentage_NN was_VBD observed_VBN after_IN challenge_NN with_IN L._NP monocytogenes_NNS in_IN animals_NNS fed_VBD diets_NNS containing_VBG either_DT lard_NN oil_NN ,_, hydrogenated_VBD coconut_JJ oil_NN ,_, or_CC palm_NN oil_NN ._SENT These_DT mice_NNS were_VBD inoculated_VBN with_IN a_DT lethal_JJ dose_NN of_IN a_DT virulent_JJ L._NP monocytogenes_NNS strain_NN ,_, a_DT facultative_JJ intracellularly_RB growing_VBG bacterium_NN that_WDT has_VBZ been_VBN used_VBN as_IN a_DT model_NN of_IN infectious_JJ and_CC pathogenic_JJ processes_NNS ._SENT After_IN the_DT administration_NN of_IN this_DT diet_NN different_JJ results_NNS were_VBD observed_VBN ._SENT Bacterial_JJ clearance_NN from_IN liver_NN or_CC spleen_NN was_VBD increased_VBN in_IN these_DT animals_NNS ,_, bactericidal_JJ activity_NN of_IN peritoneal_JJ cells_NNS was_VBD significantly_RB reduced_VBN ,_, and_CC cytotoxic_JJ effects_NNS due_JJ to_TO bacterial_JJ infection_NN were_VBD increased_VBN ,_, whereas_IN the_DT susceptibility_NN of_IN cells_NNS to_TO adhesion_NN or_CC invasion_NN by_IN L._NP monocytogenes_NNS infection_NN was_VBD substantially_RB modified_VBN ._SENT These_DT observations_NNS indicate_VBP the_DT loss_NN of_IN capacity_NN of_IN the_DT immune_JJ system_NN from_IN animals_NNS fed_VBD a_DT diet_NN containing_VBG fish_NN oil_NN to_TO destroy_VB and_CC eliminate_VB the_DT infectious_JJ agents_NNS ._SENT A_DT recent_JJ investigation_NN has_VBZ contributed_VBN to_TO explaining_VBG in_IN part_NN the_DT reasons_NNS for_IN which_WDT n-3_JJ polyunsaturated_JJ fatty_JJ acids_NNS reduce_VB host_NN defense_NN against_IN L._NP monocytogenes_NNS :_: consumption_NN of_IN EPA_NP or_CC DHA_NP (_( both_CC contained_VBN in_IN fish_NN oil_NN )_) impairs_VBZ the_DT production_NN of_IN IL-12_NP and_CC IFN-gamma_NP ,_, cytokines_NNS that_WDT play_VBP an_DT essential_JJ role_NN in_IN the_DT innate_JJ and_CC adaptive_JJ responses_NNS of_IN host_NN immune_JJ system_NN ._SENT Hence_RB ,_, the_DT reduction_NN of_IN IL-12_JJ levels_NNS may_MD explain_VB the_DT impaired_JJ bacterial_JJ clearance_NN and_CC the_DT reduction_NN of_IN survival_NN to_TO L._NP monocytogenes_NNS infection_NN ._SENT Another_DT possible_JJ explanation_NN for_IN the_DT reduction_NN of_IN host_NN resistance_NN is_VBZ based_VBN on_IN the_DT inhibition_NN of_IN the_DT expression_NN of_IN MHC_NP class_NN II_NP (_( called_VBN Ia_NP in_IN mice_NNS )_) that_WDT is_VBZ reduced_VBN in_IN mice_NNS fed_VBD a_DT fish_NN oil_NN diet_NN and_CC infected_VBN with_IN L._NP monocytogenes_NNS ._SENT Similarly_RB ,_, it_PP is_VBZ important_JJ to_TO note_VB that_IN these_DT effects_NNS may_MD be_VB associated_VBN with_IN the_DT reported_VBN increase_NN of_IN reactive_JJ oxygen_NN species_NNS ,_, whose_WP$ numbers_NNS were_VBD significantly_RB increased_VBN in_IN mice_NNS after_IN the_DT animals_NNS were_VBD experimentally_RB infected_VBN with_IN this_DT bacterium_NN and_CC fed_VBD a_DT diet_NN containing_VBG hydrogenated_VBN coconut_JJ oil_NN ._SENT In_IN fact_NN ,_, the_DT role_NN of_IN cellular_JJ oxidative_JJ processes_NNS requires_VBZ considerable_JJ attention_NN because_IN they_PP play_VBP an_DT important_JJ role_NN in_IN the_DT elimination_NN of_IN infectious_JJ agents_NNS ._SENT However_RB ,_, not_RB all_DT polyunsaturated_JJ fatty_JJ acids_NNS are_VBP capable_JJ of_IN exerting_VBG the_DT same_JJ effects_NNS ,_, since_IN many_JJ studies_NNS are_VBP not_RB in_IN accordance_NN with_IN the_DT previously_RB described_VBN arguments_NNS ._SENT Thus_RB ,_, a_DT recent_JJ investigation_NN has_VBZ determined_VBN that_IN conjugated_JJ linoleic_JJ acid_NN does_VBZ not_RB alter_VB the_DT resistance_NN of_IN mice_NNS after_IN L._NP monocytogenes_NNS infection_NN ._SENT Similarly_RB ,_, a_DT previous_JJ study_NN indicated_VBD the_DT irrelevant_JJ effect_NN of_IN dietary_JJ lipid_NN manipulation_NN on_IN the_DT survival_NN of_IN mice_NNS in_IN two_CD models_NNS of_IN peritonitis_NN ,_, one_CD with_IN Pseudomonas_NP aeruginosa_NP and_CC the_DT other_JJ with_IN Salmonella_NP enterica_NP serovar_NN Typhimurium_NN ._SENT Irrespective_RB of_IN these_DT findings_NNS ,_, other_JJ experimental_JJ studies_NNS have_VBP demonstrated_VBN the_DT adverse_JJ effects_NNS of_IN dietary_JJ lipids_NNS containing_VBG n-3_JJ or_CC n-6_JJ polyunsaturated_JJ fatty_JJ acids_NNS in_IN the_DT impairment_NN of_IN immune_JJ functions_NNS in_IN animals_NNS experimentally_RB infected_VBN with_IN different_JJ pathogenic_JJ agents_NNS such_JJ as_IN S._NP enterica_NP serovar_NP Typhimurium_NP ,_, P._NP aeruginosa_NP ,_, Staphylocococcus_NP aureus_NN ,_, or_CC Mycobacterium_NN tuberculosis_NN ._SENT By_IN contrast_NN ,_, it_PP has_VBZ been_VBN reported_VBN that_IN the_DT administration_NN of_IN diets_NNS containing_VBG fish_NN oil_NN does_VBZ not_RB reduce_VB the_DT survival_NN percentage_NN after_IN experimental_JJ infection_NN with_IN Klebsiella_NP pneumoniae_NNS ._SENT In_IN fact_NN ,_, dietary_JJ fish_NN oil_NN supplementation_NN increased_VBD resistance_NN to_TO infection_NN due_JJ to_TO an_DT enhancement_NN of_IN IL-1_NP and_CC TNF_NP production_NN by_IN peritoneal_JJ cells_NNS in_IN mice_NNS ._SENT It_PP is_VBZ probable_JJ that_IN the_DT discrepancy_NN in_IN these_DT findings_NNS is_VBZ due_JJ to_TO different_JJ factors_NNS that_WDT include_VBP the_DT duration_NN of_IN the_DT supplementation_NN period_NN ,_, the_DT concentration_NN of_IN fatty_JJ acids_NNS used_VBN ,_, or_CC the_DT cell_NN population_NN affected_VBN by_IN fatty_JJ acid_JJ administration_NN ._SENT Finally_RB ,_, experimental_JJ observations_NNS with_IN viruses_NNS have_VBP also_RB demonstrated_VBN that_IN influenza_NN virus_NN infection_NN in_IN animals_NNS fed_VBN fish_NN oil_NN diet_NN delays_VBZ the_DT clearance_NN due_JJ to_TO an_DT impairment_NN of_IN primary_JJ virus-specific_JJ T-cell_NN cytotoxicity_NN but_CC has_VBZ no_DT effect_NN on_IN NK_JJ cytotoxicity_NN ._SENT Nutritional_JJ status_NN is_VBZ generally_RB recognized_VBN as_IN an_DT essential_JJ factor_NN involved_VBN in_IN the_DT modulation_NN of_IN immune_JJ response_NN ,_, which_WDT may_MD be_VB determinant_JJ in_IN the_DT development_NN of_IN the_DT clinical_JJ effects_NNS derived_VBN from_IN a_DT malnutrition_NN process_NN ._SENT Thus_RB ,_, in_IN recent_JJ years_NNS the_DT effects_NNS that_IN different_JJ dietary_JJ lipids_NNS exert_VBP upon_IN immune_JJ functions_NNS have_VBP received_VBN considerable_JJ attention_NN ,_, because_IN different_JJ functions_NNS of_IN immune_JJ system_NN are_VBP altered_VBN after_IN dietary_JJ lipid_NN administration_NN ._SENT Hence_RB ,_, lymphocyte_NN proliferation_NN ,_, cytokine_NN production_NN ,_, phagocytic_JJ activity_NN ,_, adhesion_NN molecule_NN expression_NN ,_, and_CC NK_JJ cell_NN activity_NN are_VBP susceptible_JJ to_TO modification_NN by_IN the_DT action_NN of_IN certain_JJ lipids_NNS in_IN both_DT animals_NNS and_CC humans_NNS ._SENT Different_JJ mechanisms_NNS of_IN action_NN have_VBP been_VBN proposed_VBN to_TO be_VB involved_VBN in_IN these_DT processes_NNS ,_, such_JJ as_IN lipid_NN peroxidation_NN ,_, changes_NNS in_IN the_DT plasma_NN membrane_NN ,_, eicosanoid_JJ production_NN ,_, or_CC alteration_NN of_IN gene_NN expression_NN ._SENT Both_DT epidemiological_JJ and_CC experimental_JJ studies_NNS have_VBP applied_VBN the_DT beneficial_JJ properties_NNS associated_VBN to_TO a_DT modulation_NN of_IN the_DT immune_JJ functions_NNS ._SENT Thus_RB ,_, different_JJ fats_NNS such_JJ as_IN fish_NN oil_NN or_CC olive_JJ oil_NN have_VBP been_VBN applied_VBN in_IN the_DT amelioration_NN of_IN symptoms_NNS related_VBN to_TO rheumatoid_JJ arthritis_NN and_CC other_JJ inflammatory_JJ disorders_NNS due_JJ to_TO their_PP$ anti-inflammatory_JJ properties_NNS ._SENT Similarly_RB ,_, they_PP have_VBP also_RB been_VBN applied_VBN as_IN biological_JJ mediators_NNS capable_JJ of_IN exerting_VBG a_DT protective_JJ effect_NN against_IN colon_NN or_CC breast_NN cancer_NN ,_, whereas_IN other_JJ fatty_JJ acids_NNS such_JJ as_IN n-6_JJ polyunsaturated_JJ fatty_JJ acids_NNS exert_VBP a_DT chemopromotive_JJ role_NN in_IN tumorigenic_JJ processes_NNS ._SENT In_IN addition_NN ,_, these_DT effects_NNS may_MD be_VB related_VBN to_TO the_DT ability_NN of_IN several_JJ fatty_JJ acids_NNS to_TO modulate_VB apoptosis_NN by_IN different_JJ pathways_NNS ._SENT Nevertheless_RB ,_, the_DT immunosuppressant_JJ role_NN associated_VBN with_IN dietary_JJ polyunsaturated_JJ fatty_JJ acids_NNS containing_VBG fish_NN oil_NN may_MD produce_VB adverse_JJ effects_NNS because_IN they_PP reduce_VBP the_DT host_NN 's_POS natural_JJ resistance_NN against_IN pathogenic_JJ agents_NNS ._SENT Therefore_RB ,_, in_IN the_DT light_NN of_IN current_JJ experimental_JJ observations_NNS ,_, the_DT benefits_NNS of_IN administering_VBG these_DT dietary_JJ lipids_NNS should_MD be_VB weighed_VBN before_IN they_PP are_VBP applied_VBN as_IN immunosuppression_NN factors_NNS in_IN order_NN to_TO prevent_VB detrimental_JJ or_CC adverse_JJ effects_NNS caused_VBN by_IN an_DT excessive_JJ suppression_NN of_IN immune_JJ functions_NNS ._SENT Schematic_JJ representation_NN of_IN potential_JJ role_NN of_IN dietary_JJ lipids_NNS and_CC biological_JJ and_CC clinical_JJ consequences_NNS of_IN the_DT administration_NN of_IN several_JJ dietary_JJ lipids_NNS ._SENT Schematic_JJ representation_NN of_IN potential_JJ role_NN of_IN dietary_JJ lipids_NNS and_CC biological_JJ and_CC clinical_JJ consequences_NNS of_IN the_DT administration_NN of_IN several_JJ dietary_JJ lipids_NNS ._SENT PUFAs_NP ,_, polyunsaturated_JJ fatty_JJ acids_NNS ;_: MUFAs_NP ,_, monounsaturated_JJ fatty_JJ acids_NNS ;_: SFAs_NP ,_, saturated_VBD fatty_JJ acids_NNS ._SENT 